Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
| Author | |
|---|---|
| Abstract |
:
The New Approaches to Neuroblastoma Therapy Response Criteria (NANTRC) were developed to optimize response assessment in patients with recurrent/refractory neuroblastoma. Response predictors and associations of the NANTRC version 1.0 (NANTRCv1.0) and prognostic factors with outcome were analyzed. |
| Year of Publication |
:
2018
|
| Journal |
:
Pediatric blood & cancer
|
| Date Published |
:
2018
|
| ISSN Number |
:
1545-5009
|
| URL |
:
http://dx.doi.org/10.1002/pbc.26940
|
| DOI |
:
10.1002/pbc.26940
|
| Short Title |
:
Pediatr Blood Cancer
|
| Download citation |
